Canadian Tobacco, Alcohol and Drugs (CTADS) Survey: 2017 detailed tables

Table of Contents

Table 1. Smoking status and average number of cigarettes smoked per day, by age group and sex, 2017
Sex Age group
(years)
Population
estimate
('000)
Current smokers
(%)
Daily smokers
(%)
Occasional
smokers
(%)
Former
smokers
(%)
Never
smokers
(%)
Average
cigarettes
smoked per
dayFootnote 1

[95% confidence intervals in brackets]

Table 1 Note 1

Daily smokers only.

Return to table 1 note 1 referrer

Table 1 Note *

Moderate sampling variability, interpret with caution.

Return to table 1 note * referrer

Table 1 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 1 note # referrer

Table 1 Note ↑

Rounds up to whole number.

Return to table 1 note referrer

Table 1 Note↓

Rounds down to whole number.

Return to table 1 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age groups 30,291 15.1
[13.6-16.6]
10.8
[9.5-12.1]
4.3
[3.4-5.1]
25.7
[24.0-27.5]
59.2
[57.1-61.3]
13.7
[12.6-14.7]
Male 14,950 16.7
[14.4-19.0]
11.9
[9.9-13.9]
4.8
[3.5-6.0]
29.7
[27.1-32.3]
53.7
[50.6-56.7]
14.9
[13.5-16.4]
Female 15,342 13.5Footnote
[11.7-15.3]
9.7
[8.1-11.3]
3.8
[2.7-4.9]
21.9
[19.5-24.3]
64.6
[61.9-67.2]
12.1
[10.5-13.7]
Both
sexes
15-19 2,023 7.9
[6.4-9.3]
2.9
[2.1-3.7]
4.9
[3.7-6.2]
0.5Footnote *,Footnote
[0.2-0.8]
91.6
[90.2-93.1]
9.4
[7.5-11.3]
20-24 2,420 16.0
[14.0-18.0]
9.0
[7.4-10.5]
7.0
[5.6-8.4]
5.7
[3.9-7.6]
78.3
[75.6-80.9]
10.7
[9.4-11.9]
25-44 9,889 17.9
[14.7-21.1]
11.9
[9.2-14.7]
6.0Footnote *
[4.0-8.1]
17.0
[13.7-20.4]
65.0
[60.8-69.3]
13.2
[10.9-15.4]
25+ 25,848 15.5Footnote
[13.8-17.3]
11.6
[10.1-13.1]
4.0
[3.0-4.9]
29.6
[27.5-31.6]
54.9
[52.4-57.3]
13.9
[12.8-15.1]
45+ 15,958 14.1
[12.2-15.9]
11.4
[9.7-13.0]
2.7Footnote *
[1.8-3.6]
37.4
[34.8-40.0]
48.6
[45.8-51.4]
14.5Footnote
[13.3-15.7]
Male 15-19 1,040 9.7
[7.3-12.2]
3.8Footnote *
[2.4-5.2]
5.9Footnote *
[3.8-8.0]
Footnote # 89.7
[87.3-92.2]
9.7
[7.0-12.3]
20-24 1,244 20.4
[17.2-23.5]
11.2
[8.9-13.4]
9.2
[6.9-11.5]
7.5Footnote *, Footnote
[4.7-10.4]
72.1
[68.1-76.1]
12.1
[10.3-13.9]
25-44 4,931 17.9
[13.2-22.6]
12.1Footnote *

[8.1-16.1]
5.9Footnote *
[3.0-8.7]
20.6
[15.2-25.9]
61.5Footnote
[54.9-68.1]
13.9
[11.1-16.7]
25+ 12,665 16.9
[14.2-19.6]
12.6
[10.3-15.0]
4.3Footnote *
[2.8-5.7]
34.2
[31.2-37.3]
48.9
[45.3-52.5]
15.3
[13.7-16.9]
45+ 7,734 16.2
[13.2-19.3]
13.0
[10.3-15.7]
3.2Footnote *
[1.7-4.8]
42.9
[39.1-46.8]
40.8
[36.7-44.9]
16.1
[14.3-17.9]
Female 15-19 983 5.9
[4.4-7.4]
2.0Footnote *
[1.3-2.8]
3.9Footnote *
[2.5-5.3]
Footnote # 93.6
[92.1-95.2]
9.0
[6.2-11.8]
20-24 1,177 11.4
[8.9-13.9]
6.6
[4.5-8.7]
4.8
[3.4-6.2]
3.9Footnote *
[1.7-6.0]
84.8
[81.5-88.0]
8.2
[6.6-9.7]
25-44 4,958 17.9
[13.6-22.3]
11.7
[8.1-15.4]
6.2Footnote *
[3.3-9.1]
13.5Footnote
[9.7-17.4]
68.5Footnote
[63.2-73.8]
12.4
[8.7-16.0]
25+ 13,182 14.3
[12.1-16.4]
10.5Footnote
[8.7-12.4]
3.7Footnote *
[2.5-4.9]
25.1
[22.4-27.9]
60.6
[57.5-63.7]
12.4
[10.6-14.1]
45+ 8,224 12.0
[9.8-14.3]
9.8
[7.8-11.9]
2.2Footnote *
[1.2-3.2]
32.1
[28.4-35.8]
55.9
[52.0-59.7]
12.4
[10.8-13.9]
Table 2. Smoking status by province, age group and sex, 2017
Smoking Status Canada NL PE NS NB QC ON MB SK AB BC

[95% confidence intervals in brackets]

Table 2 Note *

Moderate sampling variability, interpret with caution.

Return to table 2 note * referrer

Table 2 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 2 note # referrer

Table 2 Note ↑

Rounds up to whole number.

Return to table 2 note referrer

Table 2 Note↓

Rounds down to whole number.

Return to table 2 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Population estimate   ('000) 30,291 448 124 808 636 6,987 11,763 1,066 924 3,478 4,057
Current smokers
 Total 15.1
[13.6-16.6]
20.0
[14.7-25.3]
11.8
[8.2-15.4]
18.4
[14.3-22.6]
13.7
[10.0-17.5]
15.7
[12.4-19.1]
12.9
[10.4-15.4]
14.5Footnote
[10.6-18.3]
17.8
[13.9-21.6]
18.9
[14.8-22.9]
15.6
[11.4-19.8]
 15-19 7.9
[6.4-9.3]
10.0Footnote *
[5.6-14.4]
15.8Footnote *
[9.2-22.3]
9.7Footnote *
[4.8-14.6]
5.8Footnote *
[3.3-8.2]
8.3Footnote *
[5.4-11.1]
6.4Footnote *
[3.9-8.8]
14.2Footnote *
[5.4-22.9]
21.9Footnote *
[12.0-31.8]
7.0Footnote *
[3.9-10.2]
6.5Footnote * Footnote
[2.8-10.3]
 20-24 16.0
[14.0-18.0]
24.2Footnote *
[11.6-36.8]
16.2Footnote *
[9.2-23.2]
19.6Footnote *
[12.1-27.2]
20.1
[13.6-26.5]
19.6
[15.2-24.1]
12.3
[9.1-15.5]
21.1
[14.8-27.5]
23.4Footnote *
[15.7-31.0]
21.1Footnote *
[14.0-28.1]
11.7Footnote *
[4.9-18.5]
 25-44 17.9
[14.7-21.1]
Footnote # Footnote # 25.8Footnote *
[14.8-36.7]
11.0Footnote *
[5.0-16.9]
20.6Footnote *
[13.0-28.3]
14.3Footnote *
[9.0-19.6]
Footnote # Footnote # 25.1Footnote *
[16.8-33.3]
Footnote #
 25+ 15.5Footnote
[13.8-17.3]
20.4
[14.4-26.4]
11.1Footnote *
[6.9-15.3]
19.0
[14.2-23.8]
13.8
[9.6-18.1]
15.9
[12.1-19.7]
13.5Footnote
[10.6-16.4]
13.8Footnote *
[9.2-18.4]
16.9
[12.3-21.4]
19.6
[14.9-24.3]
16.7
[11.8-21.6]
 45+ 14.1
[12.2-15.9]
19.6Footnote *
[13.1-26.1]
Footnote # 15.6
[11.3-19.9]
15.2Footnote *
[9.5-20.9]
13.2
[9.0-17.3]
13.0
[9.7-16.3]
10.2Footnote *
[5.8-14.6]
19.2
[13.1-25.4]
15.0Footnote *
[9.3-20.7]
16.8
[11.6-22.0]
 Male (15+) 16.7
[14.4-19.0]
21.6Footnote *
[13.7-29.6]
13.3Footnote *
[8.0-18.6]
25.3
[18.4-32.2]
13.9Footnote *
[8.3-19.6]
17.4
[12.1-22.8]
15.9
[12.0-19.8]
16.4Footnote *
[10.5-22.3]
17.6Footnote *
[11.6-23.6]
18.6
[13.0-24.2]
14.2Footnote *
[9.1-19.2]
 Female (15+) 13.5Footnote
[11.7-15.3]
18.5Footnote * Footnote
[11.6-25.4]
10.3Footnote *
[5.2-15.5]
12.0Footnote *
[7.5-16.4]
13.5Footnote * Footnote
[8.2-18.9]
14.1
[10.0-18.2]
10.0
[7.1-13.0]
12.5Footnote * Footnote
[8.0-17.1]
18.0
[13.2-22.8]
19.1
[13.1-25.2]
17.0Footnote *
[10.5-23.5]
Former smokers
 Total 25.7
[24.0-27.5]
29.6
[24.0-35.2]
29.9
[24.3-35.5]
32.3
[27.6-37.1]
28.6
[23.6-33.5]
30.5Footnote
[26.6-34.4]
23.1
[20.1-26.2]
25.2
[21.3-29.0]
25.5Footnote
[20.7-30.3]
21.1
[17.0-25.1]
27.0
[21.9-32.0]
 15-19 0.5Footnote * Footnote
[0.2-0.8]
Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
 20-24 5.7
[3.9-7.6]
Footnote # Footnote # Footnote # Footnote # 4.8Footnote *
[2.6-6.9]
Footnote # Footnote # Footnote # Footnote # 11.6Footnote *
[5.3-18.0]
 25-44 17.0
[13.7-20.4]
15.6Footnote *
[6.3-24.8]
Footnote # Footnote # 14.4Footnote *
[7.6-21.2]
19.9Footnote *
[12.7-27.1]
14.7Footnote *
[8.9-20.4]
Footnote # 24.6Footnote *
[16.2-32.9]
15.2Footnote *
[9.3-21.1]
Footnote #
 25+ 29.6
[27.5-31.6]
33.4
[27.0-39.7]
34.1
[27.6-40.7]
37.0
[31.5-42.4]
32.5Footnote
[26.8-38.2]
34.8
[30.2-39.3]
26.8
[23.2-30.4]
29.9
[25.3-34.6]
29.6
[23.9-35.3]
24.4
[19.6-29.1]
30.5Footnote
[24.6-36.3]
 45+ 37.4
[34.8-40.0]
41.9
[33.5-50.3]
38.9
[30.8-46.9]
44.7
[38.0-51.3]
41.1
[33.0-49.2]
43.4
[37.3-49.5]
34.2
[29.7-38.8]
42.8
[35.9-49.7]
33.2
[25.6-40.9]
32.2
[25.1-39.3]
36.3
[29.6-43.0]
 Male (15+) 29.7
[27.1-32.3]
31.3
[22.8-39.9]
33.4
[24.7-42.0]
32.1
[25.2-39.1]
31.4
[23.8-39.0]
33.0
[27.1-38.8]
29.1
[24.4-33.8]
26.4
[20.8-31.9]
25.6
[17.8-33.3]
24.4
[18.7-30.2]
30.8
[22.1-39.6]
 Female (15+) 21.9
[19.5-24.3]
28.0
[20.7-35.2]
26.6
[18.8-34.3]
32.5Footnote
[25.8-39.3]
25.8
[19.5-32.1]
28.1
[22.3-33.9]
17.4
[13.5-21.4]
24.0
[18.5-29.4]
25.5Footnote
[19.5-31.4]
17.6
[12.5-22.7]
23.2
[17.3-29.1]
Never smokers
 Total 59.2
[57.1-61.3]
50.4
[44.3-56.4]
58.3
[51.9-64.7]
49.2
[44.3-54.1]
57.7
[52.2-63.2]
53.7
[49.3-58.1]
64.0
[60.5-67.5]
60.4
[55.6-65.2]
56.7
[51.4-62.0]
60.1
[55.2-65.0]
57.4
[51.1-63.8]
 15-19 91.6
[90.2-93.1]
85.7
[79.8-91.5]
83.3
[76.5-90.1]
89.8
[84.8-94.7]
93.6
[90.9-96.2]
91.3
[88.4-94.2]
93.3
[90.8-95.7]
85.7
[76.9-94.4]
77.3
[67.5-87.1]
92.5Footnote
[89.3-95.7]
93.0
[89.2-96.9]
 20-24 78.3
[75.6-80.9]
73.9
[61.3-86.5]
75.8
[67.9-83.7]
74.4
[66.1-82.8]
75.0
[68.3-81.6]
75.6
[70.9-80.3]
82.6
[78.0-87.2]
75.9
[69.4-82.3]
69.9
[61.9-77.9]
74.9
[67.8-82.0]
76.7
[67.7-85.7]
 25-44 65.0
[60.8-69.3]
62.4
[50.3-74.5]
59.6
[44.4-74.8]
52.7
[40.6-64.7]
74.6
[65.9-83.3]
59.5Footnote
[49.6-69.3]
71.1
[63.7-78.4]
70.0
[60.2-79.7]
61.9
[52.9-70.9]
59.8
[51.2-68.3]
63.1
[49.4-76.8]
 25+ 54.9
[52.4-57.3]
46.2
[39.4-53.1]
54.8
[47.3-62.2]
44.1
[38.3-49.8]
53.7
[47.5-60.0]
49.3
[44.3-54.4]
59.7
[55.6-63.9]
56.3
[50.6-62.0]
53.5Footnote
[47.3-59.7]
56.0
[50.3-61.8]
52.9
[45.5-60.2]
 45+ 48.6
[45.8-51.4]
38.5Footnote
[30.4-46.6]
52.4
[43.8-61.1]
39.7
[33.3-46.1]
43.7
[35.3-52.2]
43.4
[37.3-49.5]
52.8
[48.1-57.6]
47.1
[40.1-54.0]
47.5Footnote
[39.3-55.7]
52.8
[45.3-60.3]
47.0
[39.6-54.3]
 Male (15+) 53.7
[50.6-56.7]
47.1
[38.0-56.2]
53.3
[43.9-62.7]
42.6
[35.1-50.1]
54.7
[46.6-62.7]
49.6
[42.9-56.3]
55.0
[49.5-60.4]
57.2
[49.7-64.7]
56.9
[48.7-65.0]
57.0
[50.9-63.1]
55.0
[45.6-64.4]
 Female (15+) 64.6
[61.9-67.2]
53.5Footnote
[45.5-61.6]
63.1
[54.5-71.7]
55.5Footnote
[48.9-62.1]
60.6
[53.4-67.9]
57.8
[51.5-64.1]
72.5Footnote
[68.2-76.9]
63.5Footnote
[57.2-69.8]
56.5Footnote
[50.0-63.1]
63.2
[55.7-70.8]
59.8
[51.7-67.9]
Table 3. Nicotine dependence among daily smokers, by age group and sex, 2017
Sex Age group
(years)
Population estimate ('000) How soon after waking do you have your first cigarette?
Within 5 minutes
(%)
6-30 minutes
(%)
31-60 minutes
(%)
>60 minutes
(%)

[95% confidence intervals in brackets]

Table 3 Note *

Moderate sampling variability, interpret with caution.

Return to table 3 note * referrer

Table 3 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 3 note # referrer

Table 3 Note ↑

Rounds up to whole number.

Return to table 3 note referrer

Table 3 Note↓

Rounds down to whole number.

Return to table 3 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age
groups
3,236 15.2
[10.6-19.8]
34.4
[28.9-40.0]
23.2
[17.8-28.6]
27.2
[21.3-33.0]
Male 1,751 11.2Footnote *
[7.0-15.4]
39.5Footnote
[31.2-47.9]
23.7
[16.1-31.3]
25.5Footnote
[17.5-33.5]
Female 1,485 19.9Footnote *
[11.4-28.4]
28.4
[20.6-36.2]
22.5Footnote * Footnote
[14.5-30.5]
29.1
[20.5-37.7]
Both
sexes
15-19 59 Footnote # 19.3Footnote *
[10.2-28.5]
21.0Footnote *
[11.1-30.9]
44.2
[30.2-58.3]
20-24 215 8.9Footnote *
[5.1-12.8]
23.6
[16.1-31.0]
28.2Footnote *
[18.7-37.6]
39.3
[30.0-48.6]
25-44 1,169 Footnote # 29.4Footnote *
[18.2-40.6]
24.2Footnote *
[14.1-34.3]
33.8Footnote *
[22.6-45.0]
25+ 2,961 15.7
[10.7-20.7]
35.5Footnote
[29.5-41.6]
22.9
[17.0-28.7]
25.9
[19.6-32.2]
45+ 1,793 17.7Footnote *
[11.8-23.6]
39.5Footnote
[32.0-47.1]
22.0Footnote *
[14.7-29.3]
20.8Footnote *
[13.9-27.7]
Table 4. Quit attempts in the past 12 months, by age group and sex, daily smokers, 2017
Sex Age group
(years)
Population estimate
('000)
No attempts
(%) 
1 attempt
(%)
2-3 attempts
(%)
4 or more attempts
(%)

[95% confidence intervals in brackets]

Table 4 Note *

Moderate sampling variability, interpret with caution.

Return to table 4 note * referrer

Table 4 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 4 note # referrer

Table 4 Note ↑

Rounds up to whole number.

Return to table 4 note referrer

Table 4 Note↓

Rounds down to whole number.

Return to table 4 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age
groups
3,214 55.6
[49.1-62.1]
15.9
[10.8-21.0]
16.3
[11.6-21.0]
12.1
[8.3-16.0]
Male 1,736 56.2
[47.3-65.1]
12.0Footnote *
[5.8-18.2]
19.1Footnote *
[12.0-26.2]
12.7Footnote *
[7.2-18.2]
Female 1,478 55.0
[45.7-64.3]
20.5Footnote * Footnote
[11.6-29.5]
13.0Footnote *
[7.3-18.8]
11.4Footnote *
[5.9-17.0]
Both
sexes
15-19 58 39.0Footnote *
[24.8-53.1]
Footnote # 21.4Footnote *
[10.6-32.2]
30.3Footnote *
[16.5-44.0]
20-24 212 42.2
[33.0-51.5]
16.0Footnote *
[10.1-22.0]
21.8Footnote *
[13.2-30.3]
20.0Footnote *
[12.6-27.4]
25-44 1,169 49.3
[37.5-61.1]
24.2Footnote *
[12.1-36.2]
13.5Footnote * Footnote
[6.4-20.6]
13.0Footnote *
[5.0-21.0]
25+ 2,944 56.9
[50.0-63.9]
16.0Footnote *
[10.5-21.6]
15.8
[10.8-20.9]
11.2Footnote *
[7.0-15.4]
45+ 1,774 61.9
[53.7-70.2]
10.7Footnote *
[6.1-15.3]
17.4Footnote *
[10.5-24.3]
10.0Footnote *
[5.3-14.7]
Male 15-19 39 Footnote # Footnote # Footnote # Footnote #
20-24 134 49.5Footnote
[38.1-61.0]
13.3Footnote *
[7.3-19.2]
17.3Footnote *
[10.4-24.2]
19.9Footnote *
[9.7-30.0]
25-44 593 51.6
[35.0-68.2]
Footnote # Footnote # Footnote #
25+ 1,563 57.2
[47.5-67.0]
11.9Footnote *
[5.0-18.8]
19.1Footnote *
[11.3-27.0]
11.7Footnote *
[5.7-17.7]
45+ 970 60.6
[49.0-72.3]
Footnote # 21.3Footnote *
[10.3-32.2]
11.5Footnote * Footnote
[4.7-18.3]
Female 15-19 20 Footnote # Footnote # Footnote # Footnote #
  20-24 78 29.7Footnote *
[16.2-43.1]
20.8Footnote *
[8.2-33.4]
29.4Footnote *
[11.6-47.3]
20.1Footnote *
[8.9-31.3]
  25-44 576 47.0Footnote *
[29.4-64.6]
Footnote # Footnote # Footnote #
  25+ 1,380 56.6
[46.7-66.5]
20.7Footnote *
[11.2-30.2]
12.1Footnote *
[6.2-18.0]
10.6Footnote *
[4.7-16.6]
  45+ 804 63.5Footnote
[53.1-73.9]
Footnote # 12.7Footnote *
[5.7-19.6]
Footnote #
Table 5. Quit rates among ever smokers by time since quit, by age group and sex, 2017
Sex Age group
(years)
Population estimate
  ('000)
Total quitters
(%)
Short term quittersFootnote 1
(%)
Long term quittersFootnote 2
(%)


[95% confidence intervals in brackets]

Table 5 Note 1

Short term quitter - a former smoker who quit smoking less than one year prior to the survey. Determined by their response to the question, "When did you stop smoking? Was it less than 1 year ago, 1 to 2 years ago, 3 to 5 years ago, or more than 5 years ago?"

Return to table 5 note 1 referrer

Table 5 Note 2

Long term quitter - a former smoker who quit smoking a year or more ago and has not resumed smoking during that time frame. Determined by their response to the question, "When did you stop smoking? Was it less than 1 year ago, 1 to 2 years ago, 3 to 5 years ago, or more than 5 years ago?"

Return to table 5 note 2 referrer

Table 5 Note *

Moderate sampling variability, interpret with caution.

Return to table 5 note * referrer

Table 5 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 5 note # referrer

Table 5 Note ↑

Rounds up to whole number.

Return to table 5 note referrer

Table 5 Note↓

Rounds down to whole number.

Return to table 5 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age
groups
12,334 63.0
[60.0-66.0]
3.7
[2.6-4.9]
59.2
[56.3-62.2]
Male 6,926 64.0
[59.9-68.1]
4.5Footnote * Footnote
[2.8-6.3]
59.5Footnote
[55.4-63.6]
Female 5,408 61.7
[57.2-66.3]
2.8Footnote *
[1.5-4.1]
58.9
[54.4-63.5]
Both sexes 15-19 169 5.8Footnote *
[2.4-9.1]
Footnote # Footnote #
20-24 522 25.8
[19.1-32.6]
6.0Footnote *
[3.0-9.0]
19.8Footnote *
[13.0-26.7]
25-44 3,460 48.7
[41.6-55.8]
7.4Footnote *
[4.0-10.9]
41.3
[34.4-48.1]
25+ 11,643 65.5Footnote
[62.3-68.6]
3.7Footnote *
[2.4-4.9]
61.8
[58.7-65.0]
45+ 8,184 72.6
[69.3-75.8]
2.1Footnote *
[1.2-2.9]
70.5 Footnote
[67.2-73.8]
Male 15-19 107 Footnote # Footnote # Footnote #
20-24 347 26.9
[18.5-35.4]
6.7Footnote *
[2.3-11.1]
20.2Footnote *
[11.6-28.8]
25-44 1,898 53.4
[43.7-63.1]
Footnote # 43.5Footnote
[34.0-52.9]
25+ 6,473 66.9
[62.6-71.3]
4.4Footnote *
[2.6-6.3]
62.5 Footnote
[58.2-66.9]
45+ 4,575 72.6
[67.9-77.2]
2.2Footnote *
[0.9-3.4]
70.4
[65.7-75.1]
Female 15-19 62 Footnote # Footnote # Footnote #
20-24 175 23.6Footnote *
[12.2-35.0]
4.5Footnote * Footnote
[2.2-6.9]
19.1Footnote *
[7.5-30.7]
25-44 1,561 43.0
[33.0-53.0]
Footnote # 38.6
[28.8-48.3]
25+ 5,170 63.7
[58.9-68.4]
2.7Footnote *
[1.3-4.0]
61.0
[56.2-65.7]
45+ 3,609 72.6
[67.8-77.4]
Footnote # 70.7
[65.8-75.6]
Table 6. Cessation method(s)Footnote 1 used by currentFootnote 2 and formerFootnote 3 smokers who made a quit attempt in the past 2 years, 2017
  E-cigarette
(%)
Nicotine patch
(%)
Nicotine gum
(%)
Medication
(%)
Deal w/ friend or family member
(%)
Reduced # of cigarettes
(%)


[95% confidence intervals in brackets]

Table 6 Note 1

Respondents could provide more than one cessation method.

Return to table 6 note 1 referrer

Table 6 Note 2

Includes current smokers who attempted to quit smoking cigarettes in the past 2 years.

Return to table 6 note 2 referrer

Table 6 Note 3

Includes former smokers who successfully quit in the past 2 years.

Return to table 6 note 3 referrer

Table 6 Note *

Moderate sampling variability, interpret with caution.

Return to table 6 note * referrer

Table 6 Note ↑

Rounds up to whole number.

Return to table 6 note referrer

Table 6 Note↓

Rounds down to whole number.

Return to table 6 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total 32.4
[26.6-38.2]
24.3
[18.8-29.9]
16.1
[11.9-20.3]
14.7
[10.0-19.5]
23.2
[18.3-28.0]
62.6
[56.4-68.8]
Current smokers 32.5Footnote
[25.6-39.4]
25.9
[19.2-32.6]
17.1
[11.9-22.2]
12.4Footnote *
[7.4-17.3]
22.8
[17.3-28.2]
72.8
[66.1-79.5]
Former smokers 31.9
[21.8-42.1]
20.3Footnote *
[11.5-29.0]
13.5Footnote * Footnote
[7.0-20.0]
21.1Footnote *
[10.8-31.3]
24.3Footnote *
[14.1-34.6]
36.9
[26.1-47.7]
Table 7.  Exposure of children at home to Environmental Tobacco Smoke (ETS), by province and age group, 2017
Province % Children aged
0-11 regularly exposed
% Children aged
12-17 regularly exposed
% Children aged
0-17 regularly exposed

[Wilson score intervals in brackets]

Table 7 Note *

Moderate sampling variability, interpret with caution.

Return to table 7 note * referrer

Table 7 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 7 note # referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Canada 1.1Footnote *
[0.8-1.6]
2.7
[2.0-3.5]
1.7
[1.3-2.1]
Newfoundland and Labrador Footnote # Footnote # Footnote #
Prince Edward Island Footnote # Footnote # 2.0Footnote *
[1.1-3.5]
Nova Scotia Footnote # 4.4Footnote *
[2.6-7.2]
3.1Footnote *
[1.8-5.4]
New Brunswick Footnote # 6.1Footnote *
[3.6-10.2]
2.8Footnote *
[1.7-4.6]
Quebec Footnote # Footnote # 2.2Footnote *
[1.5-3.3]
Ontario Footnote # Footnote # 1.7Footnote *
[1.0-2.9]
Manitoba Footnote # Footnote # Footnote #
Saskatchewan Footnote # 4.6Footnote *
[2.8-7.5]
2.7Footnote *
[1.7-4.3]
Alberta Footnote # Footnote # Footnote #
British Columbia Footnote # Footnote # Footnote #
Table 8. Past-30-day use of cigarettes, any tobacco product, e-cigarettes, by age group and sex, 2017
Sex Age group
(years)
CigarettesFootnote 1
(%)
Any Tobacco ProductFootnote 2
(%)
E-cigarettes
(%)


[95% confidence intervals in brackets]

Table 8 Note 1

A past-30-day smoker has smoked one or more cigarettes in the past 30 days. This includes current smokers as well as some former, and never smokers who have smoked a cigarette in the past 30 days

Return to table 8 note 1 referrer

Table 8 Note 2

Any tobacco product includes past-30-day use of cigarettes including menthol, little cigars or cigarillos, cigars, pipe, chewing tobacco, pinch or snuff, and/or a waterpipe with tobacco. E-cigarettes are excluded.

Return to table 8 note 2 referrer

Table 8 Note *

Moderate sampling variability, interpret with caution.

Return to table 8 note * referrer

Table 8 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 8 note # referrer

Table 8 Note ↑

Rounds up to whole number.

Return to table 8 note referrer

Table 8 Note↓

Rounds down to whole number.

Return to table 8 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age
groups
15.3
[13.8-16.8]
17.8
[16.2-19.3]
2.9
[2.3-3.5]
Male 17.0
[14.7-19.3]
21.2
[18.6-23.8]
3.6
[2.7-4.5]
Female 13.6
[11.8-15.5]
14.4
[12.5-16.4]
2.2Footnote *
[1.4-2.9]
Both
sexes
15-19 6.6
[5.3-7.9]
9.2
[7.7-10.7]
6.3
[5.0-7.5]
20-24 15.6
[13.6-17.6]
20.6
[18.2-23.1]
6.0
[4.8-7.3]
25+ 16.0
[14.3-17.7]
18.2
[16.3-20.0]
2.3
[1.6-3.0]
25-44 18.7
[15.6-21.9]
22.4
[19.0-25.8]
3.2Footnote *
[1.8-4.6]
45+ 14.2
[12.4-16.1]
15.6
[13.6-17.5]
1.7Footnote *
[1.1-2.4]
Male 15-19 8.4
[6.1-10.7]
12.3
[9.7-14.9]
8.1
[6.1-10.1]
20-24 20.0
[16.8-23.2]
26.5Footnote
[22.9-30.1]
9.5Footnote
[7.1-11.8]
25+ 17.4
[14.7-20.1]
21.4
[18.4-24.4]
2.6Footnote *
[1.6-3.6]
25-44 19.6
[14.8-24.3]
25.9
[20.5-31.3]
3.7Footnote *
[1.7-5.7]
45+ 16.1
[13.0-19.2]
18.6
[15.3-21.8]
2.0Footnote *
[0.9-3.0]
Female 15-19 4.8
[3.5-6.0]
5.9
[4.5-7.3]
4.4
[3.0-5.7]
20-24 10.9
[8.5-13.3]
14.4
[11.3-17.5]
2.5Footnote * Footnote
[1.5-3.4]
25+ 14.5Footnote
[12.4-16.7]
15.1
[12.9-17.3]
2.0Footnote *
[1.1-2.8]
25-44 17.9
[13.6-22.2]
18.9
[14.5-23.4]
Footnote #
45+ 12.5Footnote
[10.1-14.9]
12.8
[10.3-15.2]
1.5Footnote * Footnote
[0.9-2.2]
Table 9.  E-cigarette status, by age group and sex, 2017
Sex Age group
(years)
Ever tried
(%)
DailyFootnote 1
(%)
OccasionalFootnote 1
(%)


[95% confidence intervals in brackets]

Table 9 Note 1

Daily and occasional users are ever-users of e-cigarettes who provided a response to the question "At the present time, do you use an electronic cigarette, also known as an e-cigarette, every day, occasionally or not at all".

Return to table 9 note 1 referrer

Table 9 Note *

Moderate sampling variability, interpret with caution.

Return to table 9 note * referrer

Table 9 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 9 note # referrer

Table 9 Note ↑

Rounds up to whole number.

Return to table 9 note referrer

Table 9 Note↓

Rounds down to whole number.

Return to table 9 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age
groups
15.4
[14.0-16.7]
0.8Footnote *
[0.5-1.0]
2.3
[1.7-2.8]
Male 18.8
[16.6-21.0]
1.3Footnote *
[0.8-1.8]
2.4
[1.7-3.2]
Female 12.0
[10.4-13.6]
0.3Footnote *
[0.1-0.4]
2.1Footnote *
[1.4-2.8]
Both
sexes
15-19 22.8
[20.6-24.9]
1.6Footnote *
[1.0-2.1]
5.1
[4.1-6.2]
20-24 29.3
[26.9-31.7]
1.3Footnote *
[0.7-1.9]
4.7
[3.5-5.9]
25-44 21.8
[18.5-25.0]
1.2Footnote *
[0.5-2.0]
1.9Footnote *
[0.7-3.0]
25+ 13.5Footnote
[11.9-15.0]
0.7Footnote *
[0.4-1.0]
1.8Footnote *
[1.2-2.4]
45+ 8.4
[6.9-9.8]
Footnote # 1.8Footnote *
[1.1-2.5]
Male 15-19 28.0
[24.3-31.8]
2.5Footnote * Footnote
[1.4-3.6]
5.5Footnote
[4.1-7.0]
20-24 37.4
[33.5-41.3]
2.1Footnote *
[1.1-3.1]
7.1
[4.9-9.3]
25-44 27.7
[22.0-33.3]
Footnote # Footnote #
25+ 16.2
[13.7-18.8]
1.1Footnote *
[0.5-1.7]
1.7Footnote *
[0.9-2.6]
45+ 8.9
[6.8-11.1]
Footnote # Footnote #
Female 15-19 17.2
[14.8-19.7]
Footnote # 4.7
[3.2-6.2]
20-24 20.7
[17.7-23.7]
Footnote # 2.2Footnote *
[1.4-3.0]
25-44 15.9
[12.1-19.7]
Footnote # Footnote #
25+ 10.8
[9.0-12.7]
Footnote # 1.9Footnote *
[1.1-2.7]
45+ 7.8
[6.0-9.7]
Footnote # 1.7Footnote *
[0.9-2.6]
Table 10.  Past-30-day use of individual tobacco products and e-cigarettes, by age group and sex, 2017
Sex Age group
(years)
Any tobacco productFootnote 1
(%)
CigarettesFootnote 2
(%)
Cigars
(%)
Little cigars or cigarillos
(%)
Pipe
(%)
Smokeless tobacco
(%)
Water-pipe w/tobacco
(%)
E-cigarettes
(%)


[95% confidence intervals in brackets]

Table 10 Note 1

Any tobacco product includes past-30-day use of cigarettes (including menthol), little cigars or cigarillos, cigars, pipe, chewing tobacco, pinch or snuff, and/or a waterpipe with tobacco. E-cigarettes are excluded.

Return to table 10 note 1 referrer

Table 10 Note 2

A past-30-day smoker has smoked one or more cigarettes in the past 30 days. This includes current smokers as well as some former, and never smokers who have smoked a cigarette in the past 30 days.

Return to table 10 note 2 referrer

Table 10 Note *

Moderate sampling variability, interpret with caution.

Return to table 10 note * referrer

Table 10 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 10 note # referrer

Table 10 Note ↑

Rounds up to whole number.

Return to table 10 note referrer

Table 10 Note↓

Rounds down to whole number.

Return to table 10 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Total All age
groups
17.8
[16.2-19.3]
15.3
[13.8-16.8]
0.8Footnote *
[0.5-1.1]
1.4
[1.0-1.8]
0.3Footnote *
[0.1-0.5]
0.7Footnote *
[0.3-1.2]
0.7Footnote *
[0.4-0.9]
2.9
[2.3-3.5]
Male 21.2
[18.6-23.8]
17.0
[14.7-19.3]
1.5Footnote *,Footnote
[0.9-2.1]
2.1
[1.4-2.8]
Footnote # 1.5Footnote *,Footnote
[0.7-2.3]
0.9Footnote *
[0.5-1.3]
3.6
[2.7-4.5]
Female 14.4
[12.5-16.4]
13.6
[11.8-15.5]
0.1Footnote *
[0.0-0.1]
Footnote # Footnote # Footnote # 0.5Footnote *,Footnote
[0.2-0.9]
2.2Footnote *
[1.4-2.9]
Both
sexes
15-19 9.2
[7.7-10.7]
6.6
[5.3-7.9]
1.0Footnote *
[0.6-1.4]
2.2Footnote *
[1.1-3.3]
Footnote # 1.6Footnote *
[0.7-2.6]
1.5Footnote *,Footnote
[0.9-2.1]
6.3
[5.0-7.5]
20-24 20.6
[18.2-23.1]
15.6
[13.6-17.6]
2.1
[1.5-2.7]
3.7Footnote *
[2.3-5.1]
Footnote # 1.4Footnote *
[0.9-2.0]
3.1Footnote *
[1.9-4.4]
6.0
[4.8-7.3]
25-44 22.4
[19.0-25.8]
18.7
[15.6-21.9]
Footnote # 1.9Footnote *
[0.9-3.0]
Footnote # Footnote # Footnote # 3.2Footnote *
[1.8-4.6]
25+ 18.2
[16.3-20.0]
16.0
[14.3-17.7]
0.6Footnote *
[0.3-1.0]
1.1Footnote *
[0.7-1.5]
Footnote # Footnote # Footnote # 2.3
[1.6-3.0]
45+ 15.6
[13.6-17.5]
14.2
[12.4-16.1]
Footnote # 0.6Footnote *
[0.3-0.9]
Footnote # Footnote # Footnote # 1.7Footnote *
[1.1-2.4]
Table 11. Mean age (in years) at first use among past-30-day users of tobacco products and e-cigarettes, by sex, 2017
  Cigarettes
(in years) 
Little cigars or cigarillos
(in years) 
Cigars
(in years) 
Tobacco pipe
(in years) 
Smokeless tobacco
(in years) 
Water-pipe w/ tobacco
(in years) 
E-cigarettes
(in years) 
Total 16.0
[15.5-16.5]
21.2
[18.7-23.7]
22.5Footnote
[18.9-26.0]
26.8
[20.4-33.2]
22.6
[16.9-28.2]
18.0
[16.4-19.7]
34.1
[31.1-37.0]
Male 16.3
[15.6-17.0]
21.2
[19.1-23.4]
22.5Footnote
[18.8-26.3]
27.7
[20.1-35.4]
22.6
[16.9-28.3]
17.4
[15.2-19.5]
32.3
[28.8-35.7]
Female 15.6
[14.9-16.4]
21.3Footnote *
[13.2-29.4]
21.7
[14.9-28.5]
Footnote # Footnote # 19.1
[17.0-21.1]
36.9
[31.5-42.4]

[95% confidence intervals in brackets]

Table 11 Note *

Moderate sampling variability, interpret with caution.

Return to table 11 note * referrer

Table 11 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 11 note # referrer

Table 11 Note ↑

Rounds up to whole number.

Return to table 11 note referrer

Table 11 Note↓

Rounds down to whole number.

Return to table 11 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 12. Perceived risk of harm from using cigarettes and e-cigarettes, overall and by smoking status, 2017
  Total
(%)
Current smokers
(%)
Former smokers
(%)
Never smokers
(%)
Smoking cigarettes once in a while
No risk 3.6
[2.8-4.3]
3.8Footnote *
[2.4-5.3]
4.8Footnote *
[3.2-6.5]
3.0
[2.1-3.8]
Slight risk 28.6
[26.7-30.5]
37.5Footnote
[32.1-42.9]
30.1
[26.2-33.9]
25.8
[23.4-28.2]
Moderate risk 34.1
[32.2-36.0]
32.5Footnote
[27.6-37.5]
27.8
[24.4-31.1]
37.2
[34.7-39.8]
Great risk 30.3
[28.5-32.2]
21.3
[16.9-25.7]
34.4
[30.3-38.5]
30.8
[28.3-33.2]
Don't know 3.4
[2.6-4.2]
4.9Footnote *
[2.4-7.3]
2.9Footnote *
[1.6-4.2]
3.2Footnote *
[2.1-4.3]
Smoking cigarettes on a regular basis
No risk 0.7Footnote *
[0.3-1.0]
Footnote # Footnote # 0.6Footnote *
[0.3-0.9]
Slight risk 1.4Footnote *
[0.9-1.9]
3.7Footnote *
[1.7-5.7]
Footnote # 0.7Footnote *
[0.4-1.0]
Moderate risk 10.6
[9.3-11.9]
18.5Footnote
[14.5-22.4]
8.9
[6.3-11.5]
9.3
[7.9-10.8]
Great risk 85.3
[83.8-86.8]
74.1
[69.4-78.7]
86.9
[83.8-90.0]
87.5Footnote  
[85.7-89.2]
Don't know 2.1
[1.4-2.7]
Footnote # 2.1Footnote *
[0.9-3.3]
1.9Footnote *
[1.1-2.7]
Using e-cigarettes once in a while
No risk 6.5Footnote
[5.6-7.4]
12.5Footnote
[9.4-15.5]
5.2Footnote *
[3.5-7.0]
5.6
[4.5-6.7]
Slight risk 22.4
[20.8-24.1]
28.7
[24.0-33.4]
19.3
[16.0-22.5]
22.3
[20.3-24.2]
Moderate risk 27.9
[26.0-29.8]
24.3
[19.4-29.2]
23.9
[20.7-27.2]
30.6
[28.0-33.1]
Great risk 19.8
[18.1-21.6]
13.1
[9.2-17.0]
20.0
[16.7-23.3]
21.5Footnote
[19.2-23.7]
Don't know 23.3
[21.5-25.1]
21.5Footnote
[17.4-25.6]
31.6
[27.8-35.4]
20.1
[17.8-22.4]
Using e-cigarettes on a regular basis
No risk 2.4
[1.8-2.9]
4.1Footnote *
[2.3-5.9]
1.9Footnote *
[1.0-2.8]
2.2Footnote *
[1.4-2.9]
Slight risk 8.4
[7.4-9.4]
13.8
[10.6-17.0]
6.5Footnote
[4.5-8.4]
7.9
[6.6-9.2]
Moderate risk 24.7
[23.1-26.3]
32.6
[27.5-37.7]
18.6
[15.6-21.7]
25.3
[23.2-27.4]
Great risk 40.4
[38.4-42.3]
26.4
[21.7-31.2]
39.3
[35.4-43.2]
44.4
[41.8-46.9]
Don't know 24.1
[22.4-25.9]
23.1
[19.0-27.2]
33.7
[29.8-37.7]
20.2
[18.0-22.5]

[95% confidence intervals in brackets]

Table 12 Note *

Moderate sampling variability, interpret with caution.

Return to table 12 note * referrer

Table 12 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 12 note # referrer

Table 12 Note ↑

Rounds up to whole number.

Return to table 12 note referrer

Table 12 Note↓

Rounds down to whole number.

Return to table 12 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 13. Illegal drug use (past 12-month and lifetime), by age group and sex, 2017
Drug Category Overall Males Females 15-19 20-24 25+
Population estimate ('000) 30,291 14,950 15,342 2,023 2,420 25,848
Cannabis use
Cannabis - lifetime 46.6
[44.3 -48.8]
52.4
[49.1 -55.7]
40.9
[37.9 -44.0]
26.9
[24.5 -29.3]
52.6
[49.4 -55.9]
47.6
[44.9 -50.2]
Cannabis - past year 14.8
[13.2 -16.4]
18.7
[16.0 -21.4]
11.1
[9.3 -12.9]
19.4
[17.4 -21.4]
33.2
[30.3 -36.2]
12.7
[10.9 -14.6]
Median age of initiation (years) 17.0
[16.4 -16.9]
17.0
[16.7 -17.3]
17.0
[16.7 -17.3]
16.0
[15.7 -16.3]
17.0
[15.7 -16.3]
18.0
[17.7 -18.3]
Mean age of initiation (years) 18.6
[18.1 -19.1]
18.3
[17.7 -18.9]
19.1
[18.3 -19.8]
15.6
[15.4 -15.8]
17.0
[16.7 -17.2]
18.9
[18.4 -19.5]
Illegal drug use past year
Cocaine/Crack 2.5 Footnote * Footnote
[1.5 -3.4]
3.7Footnote *
[1.9 -5.5]
1.3Footnote *
[0.7 -1.8]
1.6Footnote *
[1.0 -2.2]
6.2
[4.6 -7.9]
2.2Footnote *
[1.1 -3.3]
Speed/Methamphetamine/Crystal meth Footnote # Footnote # 0.08Footnote *
[0.0 -0.1]
Footnote # 1.3Footnote *
[0.6 -2.1]
Footnote #
Hallucinogens 1.5 Footnote *,Footnote
[0.9 -2.1]
2.3Footnote *
[1.1 -3.6]
0.7Footnote *
[0.3 -1.0]
2.7
[1.9 -3.5]
5.1
[3.7 -6.5]
Footnote #
Hallucinogens (including salvia) 1.5Footnote
[0.9 -2.1]
2.4Footnote *
[1.1 -3.6]
0.7Footnote *
[0.3 -1.0]
2.8
[2.0 -3.6]
5.1
[3.7 -6.5]
Footnote #
Ecstasy 0.9Footnote *
[0.4 -1.5]
Footnote # 0.6Footnote *
[0.2 -1.0]
1.6Footnote *
[0.8 -2.4]
3.1
[2.2 -4.0]
Footnote #
Salvia Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
Heroin Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
Any of 6 drugs (hallucinogens excl. salvia)Footnote 1 15.2
[13.6 -16.9]
19.3
[16.6 -22.0]
11.3
[9.5 -13.1]
19.9
[17.8 -21.9]
34.9
[31.9 -37.9]
13.0
[11.1 -14.9]
Any of 5 drugs (hallucinogens excl. salvia)Footnote 2 3.3
[2.4 -4.3]
4.9Footnote *
[3.1 -6.8]
1.8Footnote *
[1.1 -2.4]
4.1
[3.1 -5.1]
10.3
[8.3 -12.3]
2.6Footnote *
[1.5 -3.8]
Any of 6 drugs (hallucinogens incl. salvia)Footnote 1 15.2
[13.6 -16.9]
19.3
[16.6 -22.0]
11.3
[9.5 -13.1]
19.9
[17.8 -21.9]
34.9
[31.9 -37.9]
13.0
[11.1 -14.9]
Any of 5 drugs (hallucinogens incl. salvia)Footnote 2 3.3
[2.4 -4.3]
5.0Footnote *
[3.1 -6.8]
1.8Footnote *
[1.1 -2.4]
4.1
[3.1 -5.1]
10.3
[8.3 -12.3]
2.6Footnote *
[1.5 -3.8]
Any drugFootnote 3 15.7
[14.1 -17.4]
19.9
[17.1 -22.6]
11.8
[9.9 -13.6]
20.7
[18.6 -22.8]
35.5Footnote
[32.4 -38.5]
13.5Footnote
[11.6 -15.4]
Lifetime illegal drug use
Cocaine/Crack 10.4
[9.0 -11.9]
14.5Footnote
[12.0 -17.1]
6.5Footnote
[5.1 -7.9]
2.6
[1.8 -3.3]
12.5Footnote
[10.1 -14.8]
10.9
[9.2 -12.6]
Speed/Methamphetamine/Crystal meth 3.7
[2.8 -4.6]
5.4
[3.7 -7.0]
2.2Footnote *
[1.4 -2.9]
1.0Footnote *
[0.5 -1.5]
3.8
[2.9 -4.8]
3.9
[2.9 -5.0]
Hallucinogens 14.3
[12.6 -15.9]
18.6
[15.9 -21.3]
10.0
[8.0 -12.0]
4.2
[3.3 -5.2]
14.0
[11.7 -16.3]
15.1
[13.1 -17.0]
Hallucinogens (including salvia) 14.8
[13.1 -16.5]
19.2
[16.5 -21.9]
10.6
[8.6 -12.6]
4.4
[3.4 -5.4]
16.2
[13.8 -18.5]
15.5Footnote
[13.6 -17.5]
Ecstasy 7.6
[6.2 -9.0]
9.0
[6.8 -11.3]
6.2
[4.4 -8.0]
3.0
[2.0 -3.9]
12.7
[10.7 -14.7]
7.5Footnote
[5.8 -9.2]
Salvia 2.9
[2.0 -3.8]
3.6Footnote *
[2.2 -5.0]
2.2Footnote *
[1.0 -3.3]
0.8Footnote *
[0.5 -1.1]
7.1
[5.8 -8.5]
2.6Footnote *
[1.6 -3.7]
Heroin 0.7Footnote *
[0.3 -1.1]
1.0Footnote *
[0.4 -1.6]
Footnote # Footnote # Footnote # 0.8Footnote *
[0.4 -1.2]
Any of 6 drugs (hallucinogens excl. salvia)Footnote 1 47.3
[45.1 -49.6]
53.3
[50.0 -56.5]
41.6
[38.5 -44.7]
27.1
[24.7 -29.4]
53.2
[49.9 -56.5]
48.4
[45.8 -51.0]
Any of 5 drugs (hallucinogens excl. salvia)Footnote 2 18.5Footnote
[16.7 -20.4]
23.4
[20.5 -26.3]
13.8
[11.6 -16.1]
6.1
[4.9 -7.3]
22.0
[19.3 -24.7]
19.2
[17.1 -21.3]
Any of 6 drugs (hallucinogens incl. salvia)Footnote 1 47.2
[45.0 -49.5]
53.3
[50.0 -56.6]
41.6
[38.5 -44.7]
27.1
[24.7 -29.4]
53.2
[50.0 -56.5]
48.4
[45.8 -51.0]
Any of 5 drugs (hallucinogens incl. salvia)Footnote 2 18.9
[17.1 -20.8]
23.8
[20.9 -26.7]
14.2
[12.0 -16.5]
6.2
[5.0 -7.4]
23.3
[20.6 -26.0]
19.5Footnote
[17.4 -21.7]
Any drugFootnote 4 47.9
[45.6 -50.1]
53.8
[50.6 -57.1]
42.1
[39.0 -45.2]
27.5Footnote
[25.1 -29.9]
53.4
[50.1 -56.7]
48.9
[46.3 -51.6]

[95% confidence intervals in brackets]

Table 13 Note 1

Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin.

Return to table 13 note 1 referrer

Table 13 Note 2

Cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin.

Return to table 13 note 2 referrer

Table 13 Note 3

Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high.

Return to table 13 note 3 referrer

Table 13 Note 4

Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers to get high.

Return to table 13 note 4 referrer

Table 13 Note *

Moderate sampling variability, interpret with caution.

Return to table 13 note * referrer

Table 13 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 13 note # referrer

Table 13 Note ↑

Rounds up to whole number.

Return to table 13 note referrer

Table 13 Note↓

Rounds down to whole number.

Return to table 13 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 14. Psychoactive pharmaceutical drug use (past 12-month), by age group and sex, 2017
Pharmaceutical Drug Category Overall Males Females 15-19 20-24 25+
Population estimate ('000) 30,291 14,950 15,342 2,023 2,420 25,848
Pain Relievers
Pain relievers 11.8
[10.6 -13.0]
11.2
[9.4 -13.0]
12.4
[10.7 -14.1]
8.4
[6.9 -9.9]
12.0
[9.9 -14.1]
12.1
[10.6 -13.5]
Pain relievers to get high Footnote # 0.4Footnote *
[0.2 -0.6]
Footnote # 0.8Footnote *
[0.3 -1.2]
1.1Footnote *
[0.4 -1.7]
Footnote #
Pain relievers to get high - among those who have used pain relievers 1.8Footnote *
[0.9 -2.8]
3.0Footnote *
[1.1 -4.9]
Footnote # 4.5Footnote *,Footnote
[2.0 -7.0]
Footnote # Footnote #
Problematic use of pain relievers (includes to get high) Footnote # 0.5Footnote *,Footnote
[0.3 -0.8]
Footnote # 0.9Footnote *
[0.4 -1.4]
Footnote # Footnote #
Problematic use of pain relievers (includes to get high) -
among those who have used pain relievers
2.9Footnote *
[1.6 -4.2]
3.8Footnote *
[1.7 -5.9]
Footnote # 5.5Footnote *,Footnote
[2.8 -8.2]
Footnote # 1.9Footnote *
[0.7 -3.1]
Stimulants
Stimulants 2.4Footnote *
[1.6 -3.2]
2.9Footnote *
[1.6 -4.1]
2.0Footnote *
[0.9 -3.1]
5.4
[4.5 -6.4]
5.5Footnote
[4.4 -6.5]
1.9Footnote *
[0.9 -2.8]
Stimulants to get high 0.2Footnote *
[0.1 -0.3]
Footnote # 0.1Footnote *
[0.0 -0.1]
Footnote # 1.0Footnote *
[0.5 -1.5]
Footnote #
Stimulants to get high - among those who have used stimulants Footnote # Footnote # Footnote # 9.0Footnote *
[3.3 -14.8]
18.4Footnote *
[9.9 -26.9]
Footnote #
Problematic use of stimulants (includes to get high) 0.3Footnote *
[0.2 -0.5]
0.6Footnote *
[0.2 -0.9]
0.1Footnote *
[0.1 -0.2]
0.9Footnote *
[0.5 -1.3]
1.9Footnote *
[1.2 -2.5]
Footnote #
Problematic use of stimulants (includes to get high) -
among those who have used stimulants
18.8Footnote *
[10.2 -27.4]
23.9Footnote *
[10.1 -37.7]
10.4Footnote *
[5.1 -15.6]
18.0Footnote *
[10.8 -25.2]
41.0
[29.9 -52.1]
Footnote #
Sedatives
Sedatives 11.7
[10.3 -13.2]
9.1
[7.2 -10.9]
14.3
[12.1 -16.5]
5.1
[4.1 -6.0]
7.5Footnote
[6.3 -8.7]
12.6
[10.9 -14.3]
Sedatives to get high 0.2Footnote *
[0.1 -0.2]
0.2Footnote *
[0.1 -0.3]
Footnote # 0.8Footnote *
[0.4 -1.2]
0.8Footnote *
[0.3 -1.3]
Footnote #
Sedatives to get high - among those who have used sedatives 1.4Footnote *
[0.8 -2.1]
2.3Footnote *
[1.0 -3.5]
Footnote # 15.3Footnote *
[7.8 -22.8]
10.8Footnote *
[4.9 -16.8]
Footnote #
Any Pharmaceutical
Any pharmaceutical 22.2
[20.4 -24.0]
19.9
[17.4 -22.5]
24.4
[21.8 -26.9]
16.8
[15.0 -18.7]
21.2
[18.8 -23.7]
22.7
[20.6 -24.8]
Any pharmaceutical to get high Footnote # 0.7Footnote *
[0.4 -1.1]
Footnote # 1.6Footnote *
[1.0 -2.1]
2.2Footnote *
[1.4 -3.0]
Footnote #
Any pharmaceutical to get high -
among those who have used any pharmaceutical
Footnote # 3.7Footnote *
[2.0 -5.3]
Footnote # 8.7Footnote *
[5.5 -11.9]
9.8Footnote *
[6.0 -13.6]
Footnote #
Problematic use of any pharmaceutical (includes to get high) 1.2Footnote *
[0.6 -1.7]
1.1Footnote *
[0.7 -1.5]
Footnote # 2.1Footnote *
[1.4 -2.7]
3.6Footnote *
[2.3 -4.9]
Footnote #
Problematic use of any pharmaceutical to get high - among those who have used any pharmaceutical 4.8Footnote *
[2.3 -7.3]
5.6Footnote *
[3.5 -7.7]
Footnote # 11.8
[8.3 -15.3]
17.1Footnote *
[11.4 -22.8]
Footnote #

[95% confidence intervals in brackets]

Table 14 Note *

Moderate sampling variability, interpret with caution.

Return to table 14 note * referrer

Table 14 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 14 note # referrer

Table 14 Note ↑

Rounds up to whole number.

Return to table 14 note referrer

Table 14 Note↓

Rounds down to whole number.

Return to table 14 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 15. Drug harms, by age group and sex, 2017
Drug related harms in past yearFootnote 1 Overall Males Females 15-19 20-24 25+
Population estimate ('000) 30,291 14,950 15,342 2,023 2,420 25,848
Any drug harm to self - total population 4.1
[3.1 -5.1]
5.5Footnote *Footnote
[3.7 -7.3]
2.9Footnote *
[1.9 -3.9]
5.4
[4.4 -6.5]
10.1
[8.2 -12.1]
3.3Footnote *
[2.1 -4.5]
Any drug harm to self among those who have used any of 5 drugsFootnote 2 39.6Footnote *
[25.2 -53.9]
37.2Footnote *
[18.7 -55.8]
45.5Footnote *Footnote
[27.6 -63.4]
53.2Footnote *
[40.7 -65.7]
38.0Footnote *
[28.6 -47.3]
38.4Footnote *
[17.1 -59.8]
Any drug harm to self among those who have engaged in problematic use of pharmaceuticalsFootnote 3 29.2Footnote *
[12.5 -45.9]
39.8Footnote *
[22.8 -56.7]
Footnote # 37.5Footnote
[23.7 -51.3]
52.5Footnote *Footnote
[33.9 -71.2]
Footnote #
Any drug harm to self among those who have used/engaged in problematic use of any drugsFootnote 4 18.3
[14.1 -22.5]
18.8
[13.0 -24.6]
17.5Footnote
[11.9 -23.2]
24.6
[20.2 -28.9]
23.5Footnote *Footnote
[19.3 -27.6]
16.2
[10.6 -21.8]

[95% confidence intervals in brackets]

Table 15 Note 1

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 15 note 1 referrer

Table 15 Note 2

Among those who have used any of 5 drugs (cocaine/crack, speed/methamphetamine/crystal meth, hallucinogens including salvia, ecstasy, heroin) in the past year. Drug related harms in the past year are due to any drug use. Users of any 5 drugs may also have used other drugs, including cannabis, or misused pharmaceuticals.

Return to table 15 note 2 referrer

Table 15 Note 3

Among those who have engaged in problematic use of pharmaceuticals (abuse of pain killers, abuse of stimulants, sedatives to get high) in the past year. Drug related harms in the past year are due to any drug use. Misusers of pharmaceuticals may also have used illegal drugs.

Return to table 15 note 3 referrer

Table 15 Note 4

Among those who have used any drug (cannabis, cocaine/crack, speed/methamphetamine/crystal meth, hallucinogens including salvia, ecstasy, inhalants, heroin, misuse of pain killers, misuse of stimulants, sedatives to get high) in the past year.

Return to table 15 note 4 referrer

Table 15 Note *

Moderate sampling variability, interpret with caution.

Return to table 15 note * referrer

Table 15 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 15 note # referrer

Table 15 Note ↑

Rounds up to whole number.

Return to table 15 note referrer

Table 15 Note↓

Rounds down to whole number.

Return to table 15 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 16. Illegal drug use (past 12-month and lifetime), by province, 2017
Drug Category / Indicator Canada NL PE NS NB QC ON MB SK AB BC 
Population estimate ('000) 30,291 448 124 808 636 6,987 11,763 1,066 924 3,478 4,057
Cannabis use
Cannabis - lifetime 46.6 44.7 46.8 52.1 47.2 43.0 44.9 42.4 44.2 49.2 55.8
Cannabis - past year 14.8 11.9 14.6 18.8 13.2 11.0 14.0 15.7 12.5Footnote 15.0 23.4
Illegal drug use past year
Cocaine/Crack 2.5Footnote *,Footnote Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # 1.5Footnote *,Footnote Footnote # Footnote # Footnote #
Speed/Methamphetamine/Crystal meth Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
Hallucinogens 1.5Footnote *,Footnote Footnote # 0.2Footnote * Footnote # Footnote # 0.4Footnote * Footnote # Footnote # Footnote # Footnote # Footnote #
Ecstasy 0.9Footnote * Footnote # Footnote # 0.2Footnote * Footnote # Footnote # 0.3Footnote * Footnote # Footnote # Footnote # 1.4Footnote *
Salvia Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
Heroin Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
Any of 6 drugs (hallucinogens excl. salvia)Footnote 1 15.2 12.7 14.6 18.8 13.4 11.7 14.3 15.8 12.6 15.6 23.8
Any of 5 drugs (hallucinogens excl. salvia)Footnote 2 3.3 Footnote # Footnote # 2.6Footnote * 0.9Footnote * 3.0Footnote * 3.0Footnote * Footnote # 2.1Footnote * 3.9Footnote * Footnote #
Any drugFootnote 3 15.7 13.2 15.0 19.0 14.2 12.3 14.7 16.3 14.2 15.9 24.4
Lifetime illegal drug use
Cocaine/Crack 10.4 7.2Footnote * 5.7Footnote * 11.7Footnote * 4.6Footnote * 10.8 7.8 9.5Footnote *,Footnote 9.6Footnote * 10.2 19.2
Speed/Methamphetamine/Crystal meth 3.7 Footnote # Footnote # Footnote # 4.0Footnote * 6.5Footnote *,Footnote 2.7Footnote * Footnote # 1.8Footnote * 2.9Footnote * Footnote #
Hallucinogens 14.3 10.7Footnote * 11.0Footnote * 16.6 11.9Footnote * 11.5Footnote 11.8 14.1Footnote * 11.1 18.2 23.8
Ecstasy 7.6 4.8Footnote * 3.9Footnote * 6.7Footnote * 3.2Footnote * 8.2Footnote * 5.7Footnote * 5.5Footnote *Footnote 3.8Footnote * 9.8Footnote * 13.0Footnote *
Salvia 2.9 Footnote # Footnote # 4.2Footnote * 2.9Footnote * 1.8Footnote * 2.8Footnote * 3.0Footnote * Footnote # 3.3Footnote * Footnote #
Heroin 0.7Footnote * Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote # Footnote #
Any of 6 drugs (hallucinogens excl. salvia)Footnote 1 47.3 45.2 46.9 52.4 48.2 44.9 45.1 42.7 45.7 49.5Footnote *,Footnote 56.7
Any of 5 drugs (hallucinogens excl. salvia)Footnote 2 18.5Footnote 12.2Footnote * 12.4Footnote * 20.5Footnote *,Footnote 15.4 18.5Footnote *,Footnote 14.9 16.9 15.4 22.1 28.3
Any drugFootnote 3 47.9 45.5Footnote 47.4 52.7 48.3 45.7 45.5Footnote 44.5Footnote 46.6 49.8 57.2
Drug related harms in past yearFootnote 4
Any drug harm to self - total populationFootnote 5 4.1 Footnote # Footnote # 3.5Footnote *,Footnote 2.4Footnote * 3.6Footnote * 4.0Footnote * 2.1Footnote * 5.4Footnote * 3.9Footnote * 6.6Footnote *

[95% confidence intervals in brackets]

Table 16 Note 1

Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin.

Return to table 16 note 1 referrer

Table 16 Note 2

Cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin.

Return to table 16 note 2 referrer

Table 16 Note 3

Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, salvia, heroin, inhalants, problematic use of pain relievers to get high.

Return to table 16 note 3 referrer

Table 16 Note 4

At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems.

Return to table 16 note 4 referrer

Table 16 Note 5

Asked of those who used any drug (cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens including salvia, heroin, inhalants, problematic use of pain relievers, stimulants and sedatives to get high); present among total population.

Return to table 16 note 5 referrer

Table 16 Note *

Moderate sampling variability, interpret with caution.

Return to table 16 note * referrer

Table 16 Note #

High sampling variability - although an estimate may be determined from the table, data should be suppressed.

Return to table 16 note # referrer

Table 16 Note ↑

Rounds up to whole number.

Return to table 16 note referrer

Table 16 Note↓

Rounds down to whole number.

Return to table 16 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 17. Alcohol indicators, by age group and sex, 2017
Alcohol indicator Overall Males Females 15-19 20-24 25+
Population estimate ('000) 30,291 14,950 15,342 2,023 2,420 25,848
Alcohol
Lifetime use 90.3
[89.1 -91.4]
91.6
[90.0 -93.2]
89.0
[87.3 -90.7]
64.2
[61.7 -66.7]
88.3
[84.9 -91.6]
92.5Footnote
[91.2 -93.8]
Past 12 month use 78.2
[76.5 -79.9]
79.5Footnote
[76.9 -82.0]
76.9
[74.6 -79.3]
56.8
[54.1 -59.5]
83.5Footnote
[80.1 -86.8]
79.4
[77.4 -81.3]
Mean age of initiation (years) 18.3
[18.0 -18.5]
17.7
[17.3 -18.0]
18.9
[18.5 -19.3]
15.8
[15.7 -16.0]
16.9
[16.8 -17.1]
18.5Footnote
[18.3 -18.8]
Exceeding low-risk drinking guidelines (LRDG)Footnote 1
Exceeds LRDG chronic 16.1
[14.4 -17.8]
17.6
[15.0 -20.3]
14.6
[12.5 -16.8]
10.3
[7.8 -12.8]
24.1
[21.4 -26.7]
15.8
[13.8 -17.8]
Exceeds LRDG acute 11.5Footnote
[10.0 -13.0]
13.1
[10.8 -15.3]
9.9
[8.1 -11.8]
6.6
[5.3 -7.9]
19.6
[17.1 -22.2]
11.1
[9.4 -12.8]
Exceeds LRDG chronic - among those who drink 20.8
[18.6 -22.9]
22.3
[19.1 -25.6]
19.2
[16.4 -21.9]
18.4
[14.3 -22.5]
28.9
[26.0 -31.9]
20.1
[17.6 -22.5]
Exceeds LRDG acute - among those who drink 14.8
[13.0 -16.7]
16.6
[13.8 -19.4]
13.0
[10.6 -15.5]
11.8
[9.5 -14.1]
23.6
[20.8 -26.5]
14.1
[12.0 -16.3]

[95% confidence intervals in brackets]

Table 17 Note 1

Based on alcohol consumption in the previous 7 days.

Return to table 17 note 1 referrer

Table 17 Note ↑

Rounds up to whole number.

Return to table 17 note referrer

Table 17 Note↓

Rounds down to whole number.

Return to table 17 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 18. Alcohol indicators, by province, 2017
Alcohol indicator Canada NL PE NS NB QC ON MB SK AB BC 
Population estimate ('000) 30,291 448 124 808 636 6,987 11,763 1,066 924 3,478 4,057
Alcohol
Lifetime use 90.3 91.7 91.4 92.7 90.3 93.7 88.3 87.8 91.3 89.3 90.9
Past 12 month use 78.2 77.4 68.4 73.8 74.9 84.2 75.6 71.0 78.4 78.8 78.5Footnote
Exceeding low-risk drinking guidelines (LRDG)Footnote 1
Exceeds LRDG chronic 16.1 18.4 18.4 17.0 14.4 16.6 15.8 14.4 11.1 14.5Footnote 18.8
Exceeds LRDG acute 11.5Footnote 14.0Footnote * 15.1Footnote * 13.8Footnote * 12.3 12.6 10.2 11.0Footnote * 9.5Footnote *Footnote 8.9 15.2Footnote *
Exceeds LRDG chronic - among those who drink 20.8 23.8 27.1 23.2 19.4 19.8 21.1 20.5Footnote 14.3 18.5Footnote 24.1
Exceeds LRDG acute - among those who drink 14.8 18.1 22.3Footnote * 18.9 16.4 15.0 13.6 15.7Footnote * 12.2Footnote * 11.4 19.4Footnote *

[95% confidence intervals in brackets]

Table 18 Note 1

Based on alcohol consumption in the previous 7 days.

Return to table 18 note 1 referrer

Table 18 Note *

Moderate sampling variability, interpret with caution.

Return to table 18 note * referrer

Table 18 Note ↑

Rounds up to whole number.

Return to table 18 note referrer

Table 18 Note↓

Rounds down to whole number.

Return to table 18 note referrer

Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 19. Description of the sample, Canada, 2017
  Canada NL PE NS NB QC ON MB SK AB BC 
Male 7,847 664 519 578 727 994 1,738 656 564 710 697
Female 8,502 691 561 662 787 1,086 1,898 712 633 734 738
15-19 5,072 466 330 371 487 604 1,124 416 355 496 423
20-24 5,250 393 321 363 444 704 1,265 490 377 434 459
25+ 6,027 496 429 506 583 772 1,247 462 465 514 553
25-34 809 56 46 66 69 104 169 64 77 90 68
35-44 991 82 49 59 107 130 201 81 86 108 88
45-54 1,824 192 146 145 192 221 391 131 120 134 152
55+ 2,403 166 188 236 215 317 486 186 182 182 245
Total  16,349 1,355 1,080 1,240 1,514 2,080 3,636 1,368 1,197 1,444 1,435

Source:  Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: